Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-01-18
1993-07-20
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 530300, 530328, A61K 3764, A61K 3702, C07K 706
Patent
active
052293670
ABSTRACT:
The synthetic peptide of formula (I) H-Ser-His-Leu-Arg-Lys-Val-Phe-Asp-Lys-OH (SEQ ID NO. 1) and its physiologically acceptable organic or inorganic salts are novel. The synthetic peptide (I), whose amino acid sequence corresponds to that of the sequence 204-212 of human lipocortin V, shows in vitro the capability of inhibiting the prostaglandin E2 release and in vivo an antiinflammatory activity. The peptide and its organic and inorganic salts are useful as therapeutic agents for the treatment of dermatological and collagen inflammatory infections.
REFERENCES:
patent: 4895931 (1990-01-01), Okazaki et al.
patent: 5081019 (1992-01-01), Wallner et al.
Devereaux et al., 12 Nucleic Acid Res. 387-395 (1984).
Cirino et al., 86 Proc. Natl. Acad. Sci. USA 3428-3432 (1989).
Cirino et al., 166 Eur. J. Pharmacol. 505-510 (1989).
K. S. Huang et al., Journal of Biological Chemistry 262:7639-7645, Jun. 5, 1987.
B. P. Wallner et al., Nature 320:77-81, Mar. 6, 1986.
L. Miele et al., Nature 335:726-730, Oct. 20, 1988.
Becherucci Cristina
Mugridge Kenneth G.
Parente Luca
Perretti Mauro
Presentini Rivo
Sclavo S.p.A.
Walsh Stephen
Wax Robert A.
LandOfFree
Antiinflammatory peptide derived from human lipocortin V does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiinflammatory peptide derived from human lipocortin V, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiinflammatory peptide derived from human lipocortin V will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760531